E V Gavrishina - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Klinicheskaia Meditsina|May 25, 2007

[A clinicoeconomic model of basic therapy for bronchial asthma]V V Arkhipov, A N Tsoĭ, E V Gavrishina

Eksperimental'Naia I Klinicheskaia Farmakologiia|August 22, 2015

[PLANNING THE DESIGN AND ESTIMATING THE RESULTS OF INVESTIGATIONS OF BIOEQUIVALENCE OF HIGHLY VARIABLE DRUGS BY EXAMPLE OF ROSUVASTATIN]D P Romodanovskii, M A Dranitsyna, D V Goryachev, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|August 22, 2015

[JUSTIFICATION OF USING EQUIVALENCE OF THE INDICES OF QUALITY, SAFETY, AND EFFICACY IN DEVELOPING BIOANALOGS]R R Niyazov, D V Goryachev, E V Gavrishina, et al.

Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|April 18, 2014

[Demonstration of quality, safety and efficacy of biological products subject to changes in their manufacturing process]A N Vasil'ev, E V Gavrishina, R R Niiazov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|March 29, 2016

[GOOD PLANNING PRACTICE IN PRECLINICAL AND CLINICAL STUDIES OF UNFRACTIONATED AND FRACTIONATED HEPARINS IN RUSSIA AS THE BASIS OF SAFE AND EFFECTIVE ANTICOAGULATION THERAPY]E V Gavrishina, A V Dobrovolskii, R R Niyazov, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Klinicheskaia Meditsina|May 25, 2007

[A clinicoeconomic model of basic therapy for bronchial asthma]V V Arkhipov, A N Tsoĭ, E V Gavrishina

Eksperimental'Naia I Klinicheskaia Farmakologiia|August 22, 2015

[PLANNING THE DESIGN AND ESTIMATING THE RESULTS OF INVESTIGATIONS OF BIOEQUIVALENCE OF HIGHLY VARIABLE DRUGS BY EXAMPLE OF ROSUVASTATIN]D P Romodanovskii, M A Dranitsyna, D V Goryachev, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|August 22, 2015

[JUSTIFICATION OF USING EQUIVALENCE OF THE INDICES OF QUALITY, SAFETY, AND EFFICACY IN DEVELOPING BIOANALOGS]R R Niyazov, D V Goryachev, E V Gavrishina, et al.

Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|April 18, 2014

[Demonstration of quality, safety and efficacy of biological products subject to changes in their manufacturing process]A N Vasil'ev, E V Gavrishina, R R Niiazov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|March 29, 2016

[GOOD PLANNING PRACTICE IN PRECLINICAL AND CLINICAL STUDIES OF UNFRACTIONATED AND FRACTIONATED HEPARINS IN RUSSIA AS THE BASIS OF SAFE AND EFFECTIVE ANTICOAGULATION THERAPY]E V Gavrishina, A V Dobrovolskii, R R Niyazov, et al.

Pageof 1